239 related articles for article (PubMed ID: 27220886)
1. Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma.
Wang D; Narula N; Azzopardi S; Smith RS; Nasar A; Altorki NK; Mittal V; Somwar R; Stiles BM; Du YN
Oncotarget; 2016 Jun; 7(26):39957-39969. PubMed ID: 27220886
[TBL] [Abstract][Full Text] [Related]
2. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer.
Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A
J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan-CD44/RHAMM interaction-dependent cell proliferation and survival in lung cancer cells.
Song JM; Im J; Nho RS; Han YH; Upadhyaya P; Kassie F
Mol Carcinog; 2019 Mar; 58(3):321-333. PubMed ID: 30365189
[TBL] [Abstract][Full Text] [Related]
4. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
5. The impact of the receptor of hyaluronan-mediated motility (RHAMM) on human urothelial transitional cell cancer of the bladder.
Niedworok C; Kretschmer I; Röck K; Vom Dorp F; Szarvas T; Heß J; Freudenberger T; Melchior-Becker A; Rübben H; Fischer JW
PLoS One; 2013; 8(9):e75681. PubMed ID: 24069434
[TBL] [Abstract][Full Text] [Related]
6. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
[TBL] [Abstract][Full Text] [Related]
7. Contribution of upregulated dipeptidyl peptidase 9 (DPP9) in promoting tumoregenicity, metastasis and the prediction of poor prognosis in non-small cell lung cancer (NSCLC).
Tang Z; Li J; Shen Q; Feng J; Liu H; Wang W; Xu L; Shi G; Ye X; Ge M; Zhou X; Ni S
Int J Cancer; 2017 Apr; 140(7):1620-1632. PubMed ID: 27943262
[TBL] [Abstract][Full Text] [Related]
8. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome.
Siegfried JM; Lin Y; Diergaarde B; Lin HM; Dacic S; Pennathur A; Weissfeld JL; Romkes M; Nukui T; Stabile LP
Neoplasia; 2015 Nov; 17(11):817-25. PubMed ID: 26678909
[TBL] [Abstract][Full Text] [Related]
9. The receptor for hyaluronan-mediated motility (RHAMM) expression in neonatal bronchiolar epithelium correlates negatively with lung air content.
Markasz L; Savani RC; Sedin G; Sindelar R
Early Hum Dev; 2018 Dec; 127():58-68. PubMed ID: 30312861
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of the receptor for hyaluronan-mediated motility, correlates with expression of microtubule-associated protein in human oral squamous cell carcinomas.
Shigeishi H; Fujimoto S; Hiraoka M; Ono S; Taki M; Ohta K; Higashikawa K; Kamata N
Int J Oncol; 2009 Jun; 34(6):1565-71. PubMed ID: 19424574
[TBL] [Abstract][Full Text] [Related]
11. Expression of the hyaluronan-mediated motility receptor RHAMM in tumor budding cells identifies aggressive colorectal cancers.
Koelzer VH; Huber B; Mele V; Iezzi G; Trippel M; Karamitopoulou E; Zlobec I; Lugli A
Hum Pathol; 2015 Nov; 46(11):1573-81. PubMed ID: 26351067
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of hyaluronan expression in non-small-cell lung cancer: Increased stromal expression indicates unfavorable outcome in patients with adenocarcinoma.
Pirinen R; Tammi R; Tammi M; Hirvikoski P; Parkkinen JJ; Johansson R; Böhm J; Hollmén S; Kosma VM
Int J Cancer; 2001 Jan; 95(1):12-7. PubMed ID: 11241304
[TBL] [Abstract][Full Text] [Related]
13. Effect of receptor for hyaluronan-mediated motility inhibition on radiosensitivity of lung adenocarcinoma A549 cells.
Gao C; Liu S; Wang Y; Cha G; Xu X
Transl Cancer Res; 2019 Apr; 8(2):410-421. PubMed ID: 35116773
[TBL] [Abstract][Full Text] [Related]
14. Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis.
Minato A; Kudo Y; Noguchi H; Kohi S; Hasegawa Y; Sato N; Hirata K; Fujimoto N
Cancer Genomics Proteomics; 2023; 20(2):203-210. PubMed ID: 36870687
[TBL] [Abstract][Full Text] [Related]
15. Expression of the Receptor for Hyaluronic Acid-Mediated Motility (RHAMM) in Endometrial Cancer is Associated With Adverse Histologic Parameters and Tumor Progression.
Schatz-Siemers N; Chen YT; Chen Z; Wang D; Ellenson LH; Du YN
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):453-459. PubMed ID: 30920393
[TBL] [Abstract][Full Text] [Related]
16. RHAMM splice variants confer radiosensitivity in human breast cancer cell lines.
Schütze A; Vogeley C; Gorges T; Twarock S; Butschan J; Babayan A; Klein D; Knauer SK; Metzen E; Müller V; Jendrossek V; Pantel K; Milde-Langosch K; Fischer JW; Röck K
Oncotarget; 2016 Apr; 7(16):21428-40. PubMed ID: 26870892
[TBL] [Abstract][Full Text] [Related]
17. Developmental regulation of hyaluronan-binding protein (RHAMM/IHABP) expression in early bovine embryos.
Stojkovic M; Krebs O; Kölle S; Prelle K; Assmann V; Zakhartchenko V; Sinowatz F; Wolf E
Biol Reprod; 2003 Jan; 68(1):60-6. PubMed ID: 12493696
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronic acid, CD44 and RHAMM regulate myoblast behavior during embryogenesis.
Leng Y; Abdullah A; Wendt MK; Calve S
Matrix Biol; 2019 May; 78-79():236-254. PubMed ID: 30130585
[TBL] [Abstract][Full Text] [Related]
19. Redox Responsive Hyaluronic Acid Nanogels for Treating RHAMM (CD168) Over-expressive Cancer, both Primary and Metastatic Tumors.
Yang C; Li C; Zhang P; Wu W; Jiang X
Theranostics; 2017; 7(6):1719-1734. PubMed ID: 28529647
[TBL] [Abstract][Full Text] [Related]
20. TGFβ and Hippo Pathways Cooperate to Enhance Sarcomagenesis and Metastasis through the Hyaluronan-Mediated Motility Receptor (HMMR).
Ye S; Liu Y; Fuller AM; Katti R; Ciotti GE; Chor S; Alam MZ; Devalaraja S; Lorent K; Weber K; Haldar M; Pack MA; Eisinger-Mathason TSK
Mol Cancer Res; 2020 Apr; 18(4):560-573. PubMed ID: 31988250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
